# CONVERGE Post-Approval Study (PAS)

> **NCT05393180** · NA · ACTIVE_NOT_RECRUITING · sponsor: **AtriCure, Inc.** · enrollment: 53 (actual)

## Conditions studied

- Chronic Atrial Fibrillation

## Interventions

- **DEVICE:** Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF

## Key facts

- **NCT ID:** NCT05393180
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-13
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-11-21
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393180, "CONVERGE Post-Approval Study (PAS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05393180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*